{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:42:13Z","timestamp":1791067333392,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1016\/j.neuropharm.2006.11.005","type":"journal-article","created":{"date-parts":[[2007,2,22]],"date-time":"2007-02-22T14:27:24Z","timestamp":1172154444000},"page":"1079-1087","source":"Crossref","is-referenced-by-count":78,"title":["Repeated treatment with cannabidiol but not \u03949-tetrahydrocannabinol has a neuroprotective effect without the development of tolerance"],"prefix":"10.1016","volume":"52","author":[{"given":"Kazuhide","family":"Hayakawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Mishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Nozako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Hazekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Hasebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Egashira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2006.11.005_bib1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-6147(92)90064-D","article-title":"Neurobiology of marijuana abuse","volume":"13","author":"Abood","year":"1992","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib2","first-page":"47","article-title":"Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil","volume":"Suppl. 3","author":"Adnot","year":"1995","journal-title":"Blood Press."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2004.11.005","article-title":"Evidence for novel cannabinoid receptors","volume":"106","author":"Begg","year":"2005","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib4","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.neuint.2006.03.015","article-title":"Estimation of the hypothermic component in neuroprotection provided by cannabinoids following cerebral ischemia","volume":"49","author":"Bonfils","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0304-3940(03)00569-X","article-title":"Post-ischemic treatment with cannabidiol prevents electroencephalographic flattening, hyperlocomotion and neuronal injury in gerbils","volume":"346","author":"Braida","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0023-6438(95)80008-5","article-title":"Use of a free radical method to evaluate antioxidant activity","volume":"28","author":"Brand-Williams","year":"1995","journal-title":"Lebensm-Wiss. Technol."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib7","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.0511232103","article-title":"Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression","volume":"103","author":"Carrier","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tips.2005.11.003","article-title":"In silico patent searching reveals a new cannabinoid receptor","volume":"27","author":"David","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neulet.2004.03.046","article-title":"Neuroprotective effect of \u03b3-glutamylethylamide (theanine) on cerebral infarction in mice","volume":"363","author":"Egashira","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0022-1759(90)90206-B","article-title":"Preparative procedures of cooling and re-warming increase leukocyte integrin expression and function on neutrophils","volume":"128","author":"Forsyth","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.neuropharm.2006.11.005_bib12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb06193.x","article-title":"Neuroprotective antioxidants from marijuana","volume":"899","author":"Hampson","year":"2000","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib13","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1073\/pnas.95.14.8268","article-title":"(\u2212) Delta9-tetrahydrocannabinol are neuroprotective antioxidant","volume":"95","author":"Hampson","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib14","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/00001756-200410250-00016","article-title":"Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism","volume":"15","author":"Hayakawa","year":"2004","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2006.11.005_bib15","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1111\/j.1460-9568.2003.03051.x","article-title":"5-HT inhibits N-type but not L-type Ca(2+) channels via 5-HT1A receptors in lamprey spinal neurons","volume":"18","author":"Hill","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1471-4159.2003.02327.x","article-title":"Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells","volume":"89","author":"Iuvone","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib17","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/1531-8249(200008)48:2<257::AID-ANA18>3.0.CO;2-P","article-title":"CB1 cannabinoid receptor induction in experimental stroke","volume":"48","author":"Jin","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib18","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1021\/jf00037a010","article-title":"Natural antioxidants in grapes and wines","volume":"42","author":"Kanner","year":"1994","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib19","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1124\/jpet.103.051961","article-title":"Evidence for cannabinoid receptor-dependent and -independent mechanisms of action in leukocytes","volume":"306","author":"Kaplan","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1096-8652(199712)56:4<244::AID-AJH8>3.0.CO;2-X","article-title":"Effects of hyporthermal stress on the ultrastructure of platelets with reference to the localization of platelet peroxidase and fibrinogen in vivo","volume":"56","author":"Kurabayashi","year":"1997","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib21","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1161\/01.STR.0000079817.68944.1E","article-title":"Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210","volume":"34","author":"Leker","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2006.11.005_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1600-0447.1999.tb10916.x","article-title":"Regional cerebral blood flow and depersonalization after tetrahydrocannabinol administration","volume":"100","author":"Mathew","year":"1999","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(02)00069-0","article-title":"Time course of tetrahydrocannabinol-induced changes in regional cerebral blood flow measured with positron emission tomography","volume":"116","author":"Mathew","year":"2002","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib24","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1254\/jjp.87.297","article-title":"Characteristics of learning and memory impairment induced by \u03949-tetrahydrocannabinol in rats","volume":"87","author":"Mishima","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1161\/01.STR.0000163083.59201.34","article-title":"Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism","volume":"36","author":"Mishima","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2006.11.005_bib28","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0028-3908(92)90055-T","article-title":"The non-competitive NMDA receptor antagonist (+)MK801 counteracts the long-lasting attenuation of the hypothermic response induced by acute doses of 8-OH-DPAT in the rat","volume":"31","author":"Renyi","year":"1992","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2006.11.005_bib29","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1046\/j.1471-4159.2000.0752080.x","article-title":"Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940","volume":"75","author":"Rubino","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib30","first-page":"37","article-title":"Agonistic properties of cannabidiol at 5-HT1a receptors","volume":"3010","author":"Russo","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib31","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(98)00634-7","article-title":"Neuroprotective effect of 5-HT1A receptor agonist, Bay X3702, demonstrated in vitro and in vivo","volume":"359","author":"Semkova","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib32","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","article-title":"Effects of chronic treatment with D9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgS autoradiography in rat brain","volume":"1","author":"Sim","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib33","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/jpet.102.035618","article-title":"Effect of chronic administration of R-(+)-[2,3-dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta (9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice","volume":"303","author":"Sim-Selly","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib34","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/jf010830b","article-title":"Free radical scavenging and antioxidative activity of caffeic acid amide and ester analogues: structure activity relationship","volume":"50","author":"Son","year":"2002","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(82)90535-0","article-title":"Difference in tolerance development of hypothermia and pentobarbital-induced sleep prolongating effect of 11-hydroxy-delta 8-detrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol in mice","volume":"77","author":"Watanabe","year":"1982","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib37","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0014-2999(83)90427-2","article-title":"Development of tolerance and cross-tolerance to the cataleptogenic effects of delta 8-tetrahydrocannabinol and 11-hydroxy-delta 8-tetrahydrocannabinol in mice","volume":"94","author":"Watanabe","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib38","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0192-0561(91)90160-9","article-title":"Marijuana components stimulate human peripheral blood mononuclear cell secretion of interferon-gamma and suppress interleukin-1 alpha in vitro","volume":"13","author":"Watzl","year":"1991","journal-title":"Int. J. Immunopharmacol."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0009-3084(02)00146-9","article-title":"Cannabinoid pharmacology: implications for additional cannabinoid receptor subtypes","volume":"121","author":"Wiley","year":"2002","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.neuropharm.2006.11.005_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0006-3223(93)90161-6","article-title":"Buspirone-induced hypothermia in normal male volunteers","volume":"34","author":"Young","year":"1993","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2006.11.005_bib41","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1248\/cpb.37.1919","article-title":"Studies on inhibition mechanism of autoxidation by tannins and flavonoids","volume":"37","author":"Yoshida","year":"1989","journal-title":"Chem. Pharm. Bull."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806003923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390806003923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T11:09:04Z","timestamp":1656068944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390806003923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0028390806003923"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2006.11.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}